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Abstract. The oxovanadium(IV) complex of oxodiacetic acid (H2ODA) 
and 2,2’-bipyridine (bipy) of stoichiometry [VO(ODA)(bipy)]⋅H2O, 
was thoroughly characterized by infrared, Raman and electronic spec-
troscopies. The biological activity of the complex on the cell prolifera-
tion was tested on osteoblast-like cells (MC3T3E1 osteoblastic mouse 
calvaria-derived cells and UMR106 rat osteosarcoma-derived cells) in 
culture. The complex caused inhibition of cellular proliferation in both 
osteoblast-like cells in culture, but its action was statistically stronger 
in the tumoral cells. This effect was specially marked with increasing 
concentrations of the complex. Based on these preliminary biological 
results, [VO(ODA)(bipy)]⋅H2O can be considered as a good candidate 
to be further investigated in relation to cancer treatment.
Keywords: Oxovanadium(IV), oxodiacetic acid, 2,2’-bipyridine, vi-
brational spectra, electronic spectra, osteoblast cells in culture, anti-
tumoral action.
Resumen. El complejo de oxovanadio(IV) del ácido oxodia-
cético (H2ODA) y 2,2’-dipiridina (bipy) de estequiometría 
[VO(ODA)(bipy)]⋅H2O, fue caracterizado detalladamente por espec-
troscopia infrarroja, Raman y electrónica. La actividad biológica del 
complejo sobre la proliferación celular fue ensayada sobre células os-
teoblásticas de fenotipo normal (MC3T3-E1) y tumorales (UMR106) 
en cultivo. El complejo fue más deletéreo sobre los osteoblastos tumo-
rales que sobre los de fenotipo normal, siendo este efecto más marcado 
con el aumento de la concentración del mismo. Los resultados de estos 
estudios biológicos permiten considerar al [VO(ODA)(bipy)]⋅H2O co-
mo un buen candidato para futuros estudios en relación a los trata-
mientos antitumorales.
Palabras clave: Oxovanadio(IV), ácido oxodiacético, 2,2’-dipiridina, 
espectros vibracionales, espectros electrónicos, osteoblastos en culti-
vo, acción antitumoral.
Introduction
The biodistribution, toxicology and biological effects of va-
nadium, as well as its pharmacological activity, are areas of 
increasing research interest [1,2]. The potentiality of simple 
vanadium compounds and complexes as therapeutic agents has 
been repeatedly emphasized in recent years and its insulin-
mimetic [1-6], anti-tumoral [2,7-10], anti-parasitic [11] and 
anti-microbial activities [12] have been reported.
Although information about the metabolism of physiologi-
cally amounts of vanadium in the higher forms of life, including 
man, remains scarce, some general aspects related to the ab-
sorption, transport, biological transformations, toxicity, excre-
tion and accumulation of vanadium are relatively well-known 
[1,13,14] In this context the fact that bone seems to be the major 
sink for retained vanadium has been unambiguously demon-
strated by numerous studies [13-15]. This fact determines the 
great interest to investigate the effects of vanadium compounds 
on osteoblast-like cells in culture.
As part of a research project devoted to the search and 
characterization of new vanadium complexes with pharmaco-
logical activity, we have now investigated the spectroscopic 
behavior and the biological effects of a new oxovanadium(IV) 
complex of stoichiometry [VO(ODA)(bipy)]⋅H2O with ODA 
= anion of the oxodiacetic acid (H2ODA = O(CH2COOH)2) 
and bipy = 2,2’-bipyridine [16], on the proliferation of two 
osteoblastic cell lines, one normal (MC3T3-E1) and the other 
tumoral (UMR106).
Results and discussion
Structural characteristics of [VO(ODA)(bipy)]⋅H2O
The crystal structure of the complex was determined by del Río 
et al. using single crystal X-ray diffractometry [16]. As shown 
in Figure 1, the coordination geometry around the metal center 
is a distorted octahedron. The basal plane is generated by the 
two bipyridine N-atoms and two carboxylic O-atoms from the 
acetate groups. The axial positions are occupied by the central 
oxygen atom of ODA and the oxo O-atom of the V=O group 
[16]. The shortest V-O distances correspond to the V=O bond 
and the V-Oether bond is somewhat longer than those to the car-
boxy-oxygens. The crystallization water molecule is involved 
in hydrogen bonds between this molecule and uncoordinated 
carboxylate oxygen atoms [16].
Vibrational spectrum of [VO(ODA)(bipy)]⋅H2O
In order to analyze the IR and Raman spectra of the com-
plex, we have compared these spectra with those of the free 
oxodiacetic acid [17], 2.2’-bipyridine [18,19] and the recently 
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investigated and related [VO(ODA)(phen)]⋅1.5H2O complex 
(ophen = 1,10-phenanthroline) [20]. The spectra obtained for 
the [VO(ODA)(bipy)]⋅H2O complex are shown in Figure 2 
and the proposed assignment is presented in Table 1. The as-
signments are additionally supported by information provided 
by well known standard reference texts [21,22] and are briefly 
commented, as follows:
- The carboxylate groups show the typical spectroscopic 
behavior expected from a monodentate interaction of this moi-
ety with the metallic center, i.e., the antisymmetric stretching 
vibration presents a lower energy than those found for the 
ν(C=O) vibration in the “free” acid (1734 cm-1), whereas the 
symmetric mode lies somewhat higher than the corresponding 
ν(C-O) mode (1309 cm-1 in the “free” acid) [17]. Besides, 
both carboxylate stretchings also show an energy difference 
(about 260 cm-1, from the IR data) which is characteristic for 
monodentate binding [23].
- Regarding the motions of the Oether bond of ODA, both 
the νas(C-O-C) and the νs(C-O-C) vibrations are slightly dis-
placed to lower energies after interaction with the metal center, 
whereas the deformational modes are less affected.
- The ν(O-H) water vibrations, centered at about 3400 
cm-1 in the IR spectrum (not shown in Figure 2), have not 
Raman counterparts. The corresponding deformational modes 
are surely overlapped by the strong and broadened νas(COO-) 
IR-band centered at 1643 cm-1.
- The characteristic ν(V=O) breathing was easy to identify 
because it generates one of the strongest Raman bands in the 
spectrum of the complex, and appears in the usually expected 
region [24] and practically in the same position as in the case 
of the [VO(ODA)(H2O)2] [17] and [VO(ODA)(phen)]⋅1.5H2O 
[20] complexes.
- The 2.2’-bipyridine bands were assigned on the basis of 
previous studies of the free molecule [18,19]. In general, most 
of the characteristic ring bands in the 1700-1300 cm-1 region 
are slightly displaced to higher frequencies upon coordination 
and slight displacements and/or intensity changes were also 
observed in other spectral regions. A similar behavior was 
Fig. 1. Schematic structure of the investigated complex, 
[VO(ODA)(bipy)]⋅H2O.
Fig. 2. FTIR (above) and FT-Raman (below) spectra of 
[VO(ODA)(bipy)]⋅H2O in the spectral range between 2000 and 400 
cm-1.

Table 1. Assignment of the vibrational spectra of [VO(ODA)(bipy)]⋅H2O 
(band positions in cm-1)
IR Raman Assignments
3438 vs,br ν(OH) (H2O)
3116 w, 3086 w, 
3033 vw
3082 m bipy - ν(CH)
2988 vw, 2931w 2985 w, 2933 m ν(CH2)
1643 vs 1670 w νas(COO-)
1605 vs, 1567 s bipy - νring
1498 w, 1473 w 1502 s bipy - νring
1443 m 1442 w bipy - νring + δring-H
1384 vs 1324 vs νs(COO-)
1316 m νring + inter ring 
stretch
1282 w, 1247 w 1273 w bipy - δ(CH)in plane
1158 m 1162 w bipy - νring + δ(CH)in 
plane
1135 m, 1106 w 1110 vw νas(C-O-C)
1072 m, 1034 m 1061 w, 1032 vs bipy - δ(CH)in plane
995 vs 996 vs ν(V=O)
976 vw, 923 s 920 w ν(C-C)
805 sh 812 w νs(C-O-C)
776 s, 733 m, 716 m 758 s bipy - δ(CH)out of plane
664 w, 652 w 646 w ρ(CH2)
616 sh, 570 w bipy - δring
515 w 512 w δ(C-O-C)
451 s, 422 sh ν(V-O)
vs, very strong; s, strong; m, medium; w, weak; vw, very weak; w, 
weak; br, broad; sh, shoulder.
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also observed in the case of the o-phenanthroline bands in 
[VO(ODA)(phen)]⋅1.5H2O [20], and it can be considered as 
characteristic of these type of ligands [25]. Interestingly, some 
of the bipy-ring motions present very high Raman intensity 
and have not IR counterparts, whereas the inter-ring stretching 
vibration could not be identified in the Raman spectrum.
- Ligand-to metal vibrations are difficult to identify. A 
pair of ν(V-O) stretching modes has been tentatively assigned 
by comparison with the results obtained in the case of the 
[VO(ODA)(H2O)2] complex [17]. ν(M-N) vibrations involving 
the nitrogen atoms of 2,2’-bipyridine are usually expected to 
lie below 300 cm-1 [23].
Electronic absorption spectrum of [VO(ODA)(bipy)]⋅H2O
The electronic absorption spectrum of the complex, measured 
in a dimethylsulfoxide solution, shows d-d transitions at 650 
nm (ε = 13 L/mol.cm), 855 nm (ε = 28 L/mol.cm) and 440 
nm (ε = 5 L/mol.cm). This spectrum is in agreement with the 
simple M.O. model proposed by Ballhausen and Gray for the 
[VO(H2O)5]2+ complex [24,26,29]. In this model, the two lower 
energy bands are assigned to the b2 → e (855 nm) and b2 → b1 
(650 nm) transitions, whereas the other one, found at 440 nm 
is probably the b2 → a1 transition.
In the precursor complex, [VO(ODA)(H2O)2], the first two 
d-d transitions are observed at 792 and 618 nm [17] whereas in 
[VO(ODA)(ophen)]⋅1.5H2O they are found at 820 and 580 nm 
[20] . As the 10 Dq parameter can be directly determined from 
the position of the b2 → b1 transition [26,27], it is clear that the 
crystal field strength generated in the present case is somewhat 
weaker to that found in the other two complexes.
Effects of [VO(ODA)(bipy)]⋅H2O on the osteoblast-like 
cell proliferation
Vanadium compounds exert different biological actions in vitro 
and in vivo systems depending on several factors not completely 
understood at present. In fact, the oxidation state and coordina-
tion sphere around the metal as well as the nature of the ligands 
and the cellular types or the in vivo models play a complex role 
in the modulation of vanadium effects [1,28,29].
Figure 3 shows the action of the oxovanadium(IV) com-
plex [VO(ODA)(bipy)]⋅H2O on osteoblast proliferation. The 
effects on two bone related cell lines, one of normal pheno-
type (MC3T3-E1) and the other tumoral, derived from a rat 
osteosarcoma (UMR106)), were evaluated by the crystal violet 
bioassay. As can be seen, the complex inhibited more strongly 
the proliferation of the osteosarcoma cells than the non-trans-
formed osteoblasts in the whole range of concentration (*p < 
0.01). Besides, it can be seen from this figure that in the high 
concentration range (50 - 100 µM), the complex was markedly 
more deleterious for the UMR106 cells than for the MC3T3-E1 
osteoblasts (#p < 0.05). At the highest tested concentration (100 
µM), the MC3T3-E1 cells showed a survival of 56% while for 
UMR106 it was of 30% (*p < 0.01), in comparison with the 
control condition.
The results of the cell culture study clearly demonstrate 
the stronger antiproliferative effect of the complex in the os-
teosarcoma UMR106 cells than in the normal cell line MC3T3- 
E1.
Comparing with related complexes of the oxovanadium(IV) 
cation with the multiple oxygen ligand oxodiacetate (ODA), the 
parent compound of this series, [VO(ODA)(H2O)2], was more 
deleterious in the normal cell line (IC50 = 50 µM) than in the 
tumoral osteoblast cell line (IC50 > 100 µM) [17,30] and an-
other ternary complex also investigated by us in osteoblasts in 
culture, [VO(ODA)phen]⋅1.5H2O, showed an IC50 of 3 µM for 
the normal osteoblasts and its IC50 value for the UMR106 cells 
was 17 µM [20]. In the present case, IC50 for MC3T3-E1 cells 
is higher than 100 µM and in UMR106 is 58 µM.
These results are very interesting also from the point 
of view of vanadium biochemistry, because they show that 
the replacement of the two water molecules in the parent 
[VO(ODA)(H2O)2] complex by one bidentate ligand produces 
significant changes in the biological activity of the compound 
and, even, the replacement by two different (bipy or ophen), 
but chemically similar, bidentate ligands, produces spectacular 
changes in the biological assays.
Conclusions
The spectroscopic behavior of the investigated 
[VO(ODA)(bipy)]⋅H2O complex, closely resembled those of 
the parent [VO(ODA)(H2O)2] and of the structurally related 
[VO(ODA)phen]⋅1.5H2O complexes. The evaluation of the an-
tiproliferative effects of [VO(ODA)(bipy)]⋅H2O on two bone 
related cell lines (one normal and one tumoral), shows that the 
Fig. 3. Effect of [VO(ODA)(bipy)]⋅H2O on the osteoblast prolifera-
tion. MC3T3-E1 and UMR106 osteoblast-like cells were incubated in 
serum free DMEM (Basal) or with the addition of different concen-
trations of the complex for 24 h at 37°C. [Results are expressed as % 
basal and represent the mean ± SEM, n = 18; *Significant differences 
vs. control, p < 0.01. # Significant differences between samples, p < 
0.05].
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complex inhibited more strongly the proliferation of the osteo-
sarcoma cells. Taking into consideration this results and the 
comparison with the related oxovanadium(IV) complexes, it is 
clear that the more deleterious action of [VO(ODA)(bipy)]⋅H2O 
on tumoral osteoblasts than on the normal cells, encourage fur-
ther studies in the field of Medicinal Chemistry exploring the 
potentiality of this complex for clinical cancer treatments.
Experimental
Materials
Oxovanadium(IV) acetylacetonate were purchased from Fluka, 
while oxodiacetic acid and 2,2’-bipyridine from Aldrich. Crys-
tal violet, p-nitrophenylphosphate (p-NPP), glycine, MgCl2, 
and all the other chemicals used in the biological activity ex-
periments were of analytical grade from Sigma Chemical Co. 
Tissue culture materials were purchased from Trading New 
Technologies (Buenos Aires, Argentina). Dulbecco’s Modi-
fied Eagles Medium (DMEM) and fetal bovine serum (FBS) 
were from GBO-Argentina S.A; trypsin-EDTA was provided 
by Gibco (Gaithersburg, ND, USA).
Synthesis of the complex
The precursor [VO(ODA)(H2O)2] was prepared by reaction 
of oxovanadium(IV) acetylacetonate and oxodiacetic acid, as 
reported earlier [16,31]. The [VO(ODA)(bipy)]⋅H2O complex 
was obtained by slow addition of 0.176 g (1 mmol) of solid 
2-2’-bipyridine to 10 mL of a methanolic solution containing 
0.235 g (1 mmol) of the precursor compound, under continu-
ous stirring. The obtained greenish micro crystalline powder 
was collected by filtration, washed with small portions of cold 
methanol and dried in air [16]. The purity was confirmed by el-
emental chemical analysis (Calcd. for C14H14N2O7V: C, 45.04; 
H, 3.75; N, 7.51%. Found: C, 45.20; H, 3.78; N, 7.45%).
Fresh stock solutions of the complex were prepared in 
dimethylsulfoxide at a 100 mM concentration and diluted ac-
cording to the experimental necessities. The stability of these 
solutions was confirmed by measuring the variation of the 
electronic absorption spectra with time.
Spectroscopic characterization
Infrared spectra in the spectral range between 4000 and 400 
cm-1 were obtained with a Bruker EQUINOX 55 Fourier trans-
form infrared spectroscopy (FTIR) instrument, using the KBr 
pellet technique. Raman spectra were measured on powdered 
samples using the FRA 106 Raman accessory of an IF66 Bruk-
er spectrophotometer. Radiation of 1064 nm from a Nd:YAG 
solid-state laser was used for excitation. Spectral resolution was 
± 4 cm-1 for both spectral measurements.
Electronic absorption spectra were measured with a Shi-
madzu model UV-300 spectrophotometer, using 10 mm-quartz 
cells.
Cell culture and cell proliferation assay
MC3T3-E1 osteoblastic cells derived from mouse calvaria and 
UMR106 tumoral cells derived from a rat osteosarcoma, were 
grown in DMEM supplemented with 100 U/ml penicillin, 100 
µg/ml streptomycin and 10% (v/v) fetal bovine serum (FBS) 
at 37 °C, 5% CO2. When the cells reached 100% confluence, 
they were sub-cultured using 0.1% trypsin plus 1 mM EDTA 
in Ca(II)-Mg(II) free phosphate buffered saline (PBS) (11 mM 
KH2PO4, 26 mM Na2HPO4, 115 mM NaCl, pH: 7.4) [32,33]. 
For the experiments, the cells (3 × 104 cells/mL) were grown 
in 48 well plates during 24 h at 37 °C. Then, the monolayer 
was incubated with different concentrations of the complex for 
the proliferation assay.
A mitogenic bioassay was carried out as described by 
Okajima et al. [34], with some modifications. Briefly, cells 
were grown in forty-eight well plates. After 24 h, they were 
incubated with different concentrations of the complex (2.5 
- 100 µM), according to the caption of Figure 3. Then, the 
monolayers were washed with PBS buffer and fixed with 5% 
glutaraldehyde/PBS at room temperature for 10 minutes. After 
that, they were stained with 0.5% crystal violet / 25% methanol 
for 10 minutes. The dye solution was discarded and the plate 
was washed with water and dried. The dye taken up by the cells 
was extracted using 0.5 ml/well 0.1 M glycine/HCl buffer, pH: 
3.0 in 30% methanol and transferred to test tubes. Absorbance 
was read at 540 nm after a convenient sample dilution. We have 
previously shown that under these conditions, the colorimetric 
bioassay strongly correlated with cell proliferation measured by 
cell counting in Neubauer chamber [32,33].
Statistical methods
At least three independent experiments were performed for 
each experimental condition. Results are expressed as %Basal 
and represent the mean ± SEM. Statistical differences were 
analyzed using the ANOVA test.
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